PLUS THERAPEUTICS Logo (WIPO, 11.12.2019)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke PLUS THERAPEUTICS wurde als Bildmarke am 11.12.2019 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Zeichen, Notationen, Symbole #Buchstaben oder Ziffern, die einen Menschen, ein Tier, eine Pflanze, einen Himmelskörper, ein Naturphänomen oder einen Gegenstand darstellen #Mathematische Zeichen #Buchstaben oder Ziffern, die einen Menschen oder einen Teil des menschlichen Körpers, ein Tier oder einen Teil des Körpers eines Tieres, eine Pflanze, einen Himmelskörper, ein Naturphänomen oder einen Gegenstand darstellen
| Markenform | Bildmarke |
| Aktenzeichen | 1525871 |
| Länder | 
|
| Basismarke |
Nr. 88470755,
12. Juni 2019
|
| Anmeldedatum | 11. Dezember 2019 |
| Ablaufdatum | 11. Dezember 2029 |
Markeninhaber
4200 Marathon Blvd., Suite 200
Austin TX 78756
US
Austin TX 78756
US
Markenvertreter
2040 MAIN STREET
14TH FLOOR
US
Waren und Dienstleistungen
05
Nanomedicinal products for medical purposes, namely organic
and inorganic pharmaceutical preparations, nanoparticle
pharmaceutical preparations, nutraceuticals,
pharmaceuticals, pharmaceutical preparations and substances
for the prevention and treatment of cancer, diabetes,
infectious diseases, autoimmune diseases and disorders,
orthopedic diseases and disorders, blood diseases and
disorders, fungal infections, diseases and disorders of the
central nervous system, oncological diseases and disorders,
and ophthalmological diseases and disorders; chemical
preparations and reagents for pharmaceutical, medical, and
clinical purposes; drug delivery agents in the form of
nanoparticle powders that facilitate the delivery of
pharmaceutical preparations; liposomal nanoparticle powders
being drug delivery agents to facilitate delivery of genetic
material and vaccines for medical purposes; all of the
aforementioned for human or animal use
40
Providing technical information in the field of
pharmaceutical manufacturing; custom manufacture of
pharmaceuticals; providing information about custom
manufacturing of pharmaceuticals in the nature of oral,
inhalatory, intramuscular, intraperitoneal, intratracheal,
intratumoral, intravenous, subcutaneous, and topical applied
aggregations of liposomes providing time-release of
encapsulated pharmaceuticals made to the order or
specification of others, for treatment of a wide variety of
diseases; custom manufacturing of pharmaceuticals in the
nature of oral, inhalatory, intramuscular, intraperitoneal,
intratracheal, intratumoral, intravenous, subcutaneous, and
topical applied aggregations of liposomes providing
time-release of encapsulated pharmaceuticals made to the
order or specification of others, for treatment of a wide
variety of diseases
42
Drug discovery services; pharmaceutical research and
development; research and development of nanomedicinal
products; scientific and medical research and development
for nutraceuticals, pharmaceuticals, pharmaceutical
preparations and substances in the field of cancer,
diabetes, infectious diseases, autoimmune diseases and
disorders, orthopedic diseases and disorders, blood diseases
and disorders, fungal infections, diseases and disorders of
the central nervous system, oncological diseases and
disorders, and ophthalmological diseases and disorders;
scientific research and development for pharmaceuticals in
the nature of oral, inhalatory, intramuscular,
intraperitoneal, intratracheal, intratumoral intravenous,
subcutaneous, and topical applied aggregations of liposomes
providing time-release of encapsulated pharmaceuticals, for
treatment of a wide variety of diseases; providing medical
and scientific information in the aforementioned fields
44
Medical services, namely, administration of nanomedicinal
medications; medical services, namely, medical consultancy
relating to nanomedicinal products
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 04. Juli 2023 | 2023/27 Gaz | TR | Ablehnung |
| 07. Juni 2023 | 2023/27 Gaz | CA | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 22. September 2022 | 2022/38 Gaz | JP | Ablehnung |
| 28. März 2022 | 2022/16 Gaz | IN | Ablehnung |
| 17. September 2021 | 2021/37 Gaz | MX | Ablehnung |
| 24. August 2021 | 2021/35 Gaz | CA | Ablehnung |
| 26. Juli 2021 | 2021/31 Gaz | KR | Ablehnung |
| 24. Juni 2021 | 2021/25 Gaz | JP | Ablehnung |
| 03. Mai 2021 | 2021/18 Gaz | RU | Ablehnung |
| 04. März 2021 | 2021/10 Gaz | EM | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 01. März 2021 | 2021/9 Gaz | ID | Ablehnung |
| 01. Februar 2021 | 2021/5 Gaz | KR | Ablehnung |
| 24. November 2020 | 2020/52 Gaz | BR | Ablehnung |
| 09. Oktober 2020 | 2020/43 Gaz | RS | Ablehnung |
| 25. September 2020 | 2020/40 Gaz | RU | Ablehnung |
| 15. September 2020 | 2020/38 Gaz | AU | Ablehnung |
| 08. September 2020 | 2020/39 Gaz | EM | Ablehnung |
| 01. September 2020 | 2020/37 Gaz | CN | Ablehnung |
| 06. Juli 2020 | 2020/29 Gaz | IN | Ablehnung |
| 29. April 2020 | 2020/35 Gaz | EM | Ablehnung |
| 11. Dezember 2019 | 2020/14 Gaz | US | Eintragung |
ID: 141525871